World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   661 records for 158 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
RecruitingISRCTN13716228
everyBody – Tailored online health promotion and eating disorder prevention for women at different risk stages
26/02/2016
RecruitingDRKS00009955
NordiNet® International Outcome Study-Observational Prospective Study on Patients Treated With Norditropin®
Recruitment statusMain IDPublic titleDate of registration
RecruitingNCT00960128Observational Prospective Study on Patients Treated With Norditropin®13/08/2009
25/01/2016
RecruitingNCT02699736
Clinical and Virological Outcome of European Patients Infected With HIV
19/01/2016
RecruitingNCT02607878
Automated Pupillometry for Coma Prognostication After Cardiac Arrest
02/11/2015
RecruitingDRKS00007600
A Prospective Registry of Patients With a Confirmed Diagnosis of Adenocarcinoma of the Prostate Presenting With Metastatic Castrate-Resistant Prostate Cancer
Recruitment statusMain IDPublic titleDate of registration
RecruitingNCT02236637A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care08/09/2014
28/10/2015
RecruitingNCT02588144
Combined Stimulation of STN and SNr for Resistant Freezing of Gait in Parkinson's Disease
24/10/2015
AuthorisedEUCTR2015-001088-38-CZ
A study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma. 12/10/2015
Not recruitingNCT02571777
Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-002899-25-EESafety and Efficacy study of QVM149 in asthmatic patients28/11/2015
AuthorisedEUCTR2015-002899-25-PTSafety and Efficacy study of QVM149 in asthmatic patients07/12/2015
AuthorisedEUCTR2015-002899-25-DESafety and Efficacy study of QVM149 in asthmatic patients04/12/2015
AuthorisedEUCTR2015-002899-25-FISafety and Efficacy study of QVM149 in asthmatic patients23/12/2015
AuthorisedEUCTR2015-002899-25-GRSafety and Efficacy study of QVM149 in asthmatic patients08/02/2016
AuthorisedEUCTR2015-002899-25-LVSafety and Efficacy study of QVM149 in asthmatic patients11/01/2016
AuthorisedEUCTR2015-002899-25-DKSafety and Efficacy study of QVM149 in asthmatic patients08/01/2016
AuthorisedEUCTR2015-002899-25-SKSafety and Efficacy study of QVM149 in asthmatic patients07/12/2015
AuthorisedEUCTR2015-002899-25-ATSafety and Efficacy study of QVM149 in asthmatic patients15/12/2015
AuthorisedEUCTR2015-002899-25-HUSafety and Efficacy study of QVM149 in asthmatic patients16/12/2015
AuthorisedEUCTR2015-002899-25-LTSafety and Efficacy study of QVM149 in asthmatic patients04/12/2015
AuthorisedEUCTR2015-002899-25-ESSafety and Efficacy study of QVM149 in asthmatic patients07/01/2016
AuthorisedEUCTR2015-002899-25-NLSafety and Efficacy study of QVM149 in asthmatic patients17/12/2015
05/10/2015
AuthorisedEUCTR2015-001088-38-FI
A study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-001088-38-ESA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.05/11/2015
AuthorisedEUCTR2015-001088-38-DEA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.23/09/2015
AuthorisedEUCTR2015-001088-38-CZA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.12/10/2015
AuthorisedEUCTR2015-001088-38-DKA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.03/11/2015
AuthorisedEUCTR2015-001088-38-GBA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.12/11/2015
RecruitingNCT02626455Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)03/11/2015
21/09/2015
RecruitingNCT02552940
An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical Practice
16/09/2015
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history